Cargando…

Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

Triple therapy of chronic hepatitis C virus (HCV) infection with boceprevir (BOC) or telaprevir (TVR) leads to virologic failure in many patients which is often associated with the selection of resistance-associated variants (RAVs). These resistance profiles are of importance for the selection of po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dietz, Julia, Rupp, Daniel, Susser, Simone, Vermehren, Johannes, Peiffer, Kai-Henrik, Filmann, Natalie, Bon, Dimitra, Kuntzen, Thomas, Mauss, Stefan, Grammatikos, Georgios, Perner, Dany, Berkowski, Caterina, Herrmann, Eva, Zeuzem, Stefan, Bartenschlager, Ralf, Sarrazin, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900565/ https://www.ncbi.nlm.nih.gov/pubmed/27281344 http://dx.doi.org/10.1371/journal.pone.0156731

Ejemplares similares

Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients
por: Dietz, Julia, et al.
Publicado: (2015)

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels
por: Grammatikos, Georgios, et al.
Publicado: (2016)

Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C
por: Susser, Simone, et al.
Publicado: (2014)

Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
por: Welsch, Christoph, et al.
Publicado: (2008)

A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2015)

Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 years
por: Graf, Christiana, et al.
Publicado: (2023)

Correction: A Conserved NS3 Surface Patch Orchestrates NS2 Protease Stimulation, NS5A Hyperphosphorylation and HCV Genome Replication
por: Isken, Olaf, et al.
Publicado: (2016)

Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instability
por: Dultz, Georg, et al.
Publicado: (2021)

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Synthetic bulky NS4A peptide variants bind to and inhibit HCV NS3 protease
por: El-Araby, Moustafa E., et al.
Publicado: (2020)

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
por: Maasoumy, Benjamin, et al.
Publicado: (2014)

Identification of NS2 determinants stimulating intrinsic HCV NS2 protease activity
por: Isken, Olaf, et al.
Publicado: (2022)

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
por: Mücke, Marcus M., et al.
Publicado: (2019)

Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir
por: Berger, Kristi L., et al.
Publicado: (2016)

A Multi-Variant, Viral Dynamic Model of Genotype 1 HCV to Assess the in vivo Evolution of Protease-Inhibitor Resistant Variants
por: Adiwijaya, Bambang S., et al.
Publicado: (2010)

Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study
por: Mücke, Marcus M, et al.
Publicado: (2018)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis
por: Hernandez Sampere, Lisa, et al.
Publicado: (2020)

Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients
por: Grammatikos, Georgios, et al.
Publicado: (2014)

No strategy to meet the HCV epidemic
por: Dalgard, Olav, et al.
Publicado: (2014)

Structural Analysis of Asunaprevir Resistance in HCV NS3/4A Protease
por: Soumana, Djadé I., et al.
Publicado: (2014)

1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease
por: Omar, Abdelsattar M., et al.
Publicado: (2020)

Serum sphingolipidomic analyses reveal an upregulation of C16- ceramide and sphingosine-1-phosphate in hepatocellular carcinoma
por: Grammatikos, Georgios, et al.
Publicado: (2016)

Natural HCV variants with increased replicative fitness due to NS3 helicase mutations in the C-terminal helix α(18)
por: Stross, Claudia, et al.
Publicado: (2016)

Metalloprotoporphyrin Inhibition of HCV NS3-4A Protease: Structure–Activity Relationships
por: Hu, Katherine, et al.
Publicado: (2020)

Potent HCV NS3 Protease Inhibition by a Water-Soluble Phyllanthin Congener
por: B, Uma Reddy, et al.
Publicado: (2020)

Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication
por: Kouretova, Jenny, et al.
Publicado: (2017)

Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis
por: Isken, Olaf, et al.
Publicado: (2022)

Engineered Toxins “Zymoxins” Are Activated by the HCV NS3 Protease by Removal of an Inhibitory Protein Domain
por: Shapira, Assaf, et al.
Publicado: (2011)

Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics
por: Oerlemans, Rick, et al.
Publicado: (2020)

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection
por: Mücke, Victoria Therese, et al.
Publicado: (2018)

Soluble Serum CD81 Is Elevated in Patients with Chronic Hepatitis C and Correlates with Alanine Aminotransferase Serum Activity
por: Welker, Martin-Walter, et al.
Publicado: (2012)

Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis
por: Finkelmeier, Fabian, et al.
Publicado: (2018)

High Prevalence of Anti-HCV Antibodies in Two Metropolitan Emergency Departments in Germany: A Prospective Screening Analysis of 28,809 Patients
por: Vermehren, Johannes, et al.
Publicado: (2012)

Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection
por: Graf, Christiana, et al.
Publicado: (2019)

AFP ratio predicts HCC recurrence after liver transplantation
por: Koch, Christine, et al.
Publicado: (2020)

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Molecular docking study of P4-Benzoxaborolesubstituted ligands as inhibitors of HCV NS3/4A protease
por: Wadood, Abdul, et al.
Publicado: (2013)

No correspondence between resistance mutations in the HCV-NS3 protease at baseline and early telaprevir-based triple therapy
por: Hoffmann, Luísa, et al.
Publicado: (2015)

The Discovery and Early Clinical Evaluation of the HCV NS3/4A Protease Inhibitor Asunaprevir (BMS-650032)
por: Meanwell, Nicholas A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pjipr6p0tdtcmibqao7aqe02mj